Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This study evaluates whether zoledronic acid can prevent the high bone turnover that occurs
after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Diphosphonates Ergocalciferols Vitamin D Vitamins Zoledronic Acid